Une conférence intitulée « Cancer and Immunity - Development of Autoantibody Biomarker Measurement Technology » aura lieu mardi 17 décembre à la Maison France Japon.
La Maison Universitaire France-Japon, en collaboration avec The Japan Society for the Promotion of Science (JSPS) et L’Institut du médicament (IMS), a le plaisir de vous convier à la conférence du Ass. Prof. Ai Miyamoto, Faculty of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Professeur invité à l'IMS
Conférence tout public - en anglais
Résumé :
Our immune system protects us by identifying and eliminating abnormal cells in the body. However, if this system stops working properly, it can lead to the development of cancer. In our research, we are focusing on autoantibodies as a way to understand how the immune system works.
These autoantibodies are indicators (biomarkers) for the level of activation of the immune system. We are developing a system (MUSCAT-assay) that can measure these autoantibodies using a small amount of blood to help diagnose cancer and predict treatment response.
